医学
弥漫性大B细胞淋巴瘤
耐火材料(行星科学)
淋巴瘤
癌症研究
抗体
肿瘤科
内科学
免疫学
天体生物学
物理
作者
Michael Dickinson,Carmelo Carlo‐Stella,Franck Morschhauser,Emmanuel Bachy,Paolo Corradini,Gloria Iacoboni,Cyrus Khan,Tomasz Wróbel,Fritz Offner,Marek Trněný,Shang-Ju Wu,Guillaume Cartron,Mark Hertzberg,Anna Sureda,David Pérez-Callejo,Linda Lundberg,James Relf,Mark R. Dixon,Emma Clark,Kathryn Humphrey,Martin Hutchings
标识
DOI:10.1056/nejmoa2206913
摘要
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is poor. Glofitamab is a bispecific antibody that recruits T cells to tumor cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI